← Back to COYA

Coya Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 11/08/2026Mar 2026Filed 11/08/2026Sep 2025Filed 12/11/2025Jun 2025Filed 11/08/2026Mar 2025Filed 11/08/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/11/2025Mar 2024Filed 12/11/2025
$0.2$0.3$3.6$0.2$0.3$0$3.4$0.1
−$6.6−$7.2−$2.1−$6.1−$7.3−$4−$2.9−$5.1
−$0.28−$0.32−$0.13−$0.36−$0.44−$0.26−$0.19−$0.35
2323171717151514

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.